TOP STORIES

• ACADEMIA Japan College of Rheumatology to Collaborate with Pfizer on PMS, Warns that Non-RA Specialists More Inclined to Prescribe Xeljanz
  May 31, 2013

• BUSINESS Astellas, Amgen Clinch Strategic Alliance on 5 Products; JV to Begin Operations in October
  May 30, 2013

• BUSINESS Ex-Novartis Employee Attended Key Panel Meetings for Diovan Trial
  May 29, 2013

• BUSINESS MTPC Files NDA for SGLT-2 Inhibitor Canagliflozin in Japan
  May 29, 2013

• REGULATORY PAFSC’s Second Committee Recommends Approval for IV Preparation of Acetaminophen
  May 28, 2013

• BUSINESS 2012 Earnings: Foreign Pharmas’ Japan Units Underperform Market Growth, Operating Profit Down 21%
  May 27, 2013

• REGULATORY First Committee Recommends Approval for Third GLP-1 Receptor Agonist Lyxumia, Others
  May 27, 2013

• REGULATORY Citations in Guidelines to Be Prerequisite for Health Coverage of Off-Label Drugs under 1980 Notification
  May 24, 2013

• BUSINESS Japan’s 1st Western Herbal Medicine Antistax to Hit Shelves in June: SSP
  May 24, 2013

• ORGANIZATION Towa’s Yoshida Appointed New JGA President, Says Achieving Roadmap Goals Important
  May 23, 2013

• BUSINESS AZ Oncology Division to Provide Information Based on Patients’ Lifestyle
  May 22, 2013

• BUSINESS Domestic Sales of Ethical Drugs Rose 0.3% to 9,560.1 Billion Yen in FY2012: IMS Japan
  May 22, 2013

• BUSINESS Allegra AGs Pitched as Affordable Original Drugs with Production by Sanofi
  May 21, 2013

• BUSINESS Takeda Slips to 3rd Place in 25 Major Pharmas’ Operating Profit Ranking
  May 20, 2013

• BUSINESS FY2012 Sales Up 18% for Both Generic-Only Makers, Research-Driven Pharmas’ Generic Units; Govt Incentive Measures Biggest Contributor
  May 17, 2013

• BUSINESS FY2012 Japan Pharma Market: Sales of Major Long-Listed Drugs Tumble 30-40%
  May 16, 2013

• REGULATORY CSIMC Approves Listing of 15 New APIs/19 Products Including Pfizer’s Xeljanz with Expected Peak Sales of 59.7 Billion Yen
  May 16, 2013

• BUSINESS Eight Companies Initiate Voluntary Recall of Enalapril Generics Due to Deviations from Specifications
  May 15, 2013

• BUSINESS Four Leading Wholesalers See Clear Recovery in Pharmaceutical Wholesale Business
  May 14, 2013

• REGULATORY PMDA-WEST to Be Launched in Osaka in October to Undertake Consultation Services, GMP Inspections
  May 13, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 216
• 217
• 218
• 219
• 220
• 221
• 222
• 223
• 224
• …
• Next ›
• 最終 »